Where this mesothelioma information comes from

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had mesothelioma, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.

US National Cancer Institute
Information on the treatment of mesothelioma
http://www.cancer.gov/cancerinfo/types/malignantmesothelioma/

Principles and practice of oncology (8th edition)
De Vita, V.T., Hellman, S. and Rosenberg S.A.
Lippincott, Williams and Wilkins, 2008

Cancer and its management (6th edition)
Tobias J and Hochhauser D
Blackwell Publishing Ltd, 2010

Statement on malignant mesothelioma (MM) in the United Kingdom
British Thoracic Society Standards of Care Committee, 2007
Link to the British Thoracic Society website

Pemetrexed for the treatment of malignant pleural mesothelioma
The National Institute for Health and Clinical Excellence (NICE), January 2008
Link to the pemetrexed for mesothelioma guidance on the NICE website

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant  pleural mesothelioma 
Scherpereel, A. et al. European Respiratory Journal, 2010; 35 (3): 479-495
Link to the European Respiratory Society website

Radiotherapy for malignant pleural mesothelioma. Chapman E, Berenstein G, García Diéguez M, Ortiz Z. Cochrane Database of Systematic Reviews 2006, Issue 3.

Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. Green JA, Dundar Y, Dodd SR, Dickson RC, Walley T. Cochrane Database of Systematic Reviews 2007, Issue 1.

Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary.Maziak D et al. Database of Abstracts of Reviews of Effects (DARE), December 2006.

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis.Berghmans T et al. Database of Abstracts of Reviews of Effects (DARE), January 2006.

Peritoneal mesothelioma: current understanding and management. Chua T, Yan T and Morris D. Canadian Journal of Surgery: 2009 Feb;52(1):59-64.

Malignant mesothelioma - Consultant Thoracic Surgeon British surgical strategies. Waller D. A. Lung Cancer, 2004, vol 455, ppS81 - 84

Malignant pleural mesothelioma:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Stahel R, Weder W, Lievens Y and Felip E. 2010. Annals of Oncology. 21 (supplement 5), v126-v128. 

Mesothelioma. Weder W. 2010 Annals of Oncology. 21 (supplement 7), vii 326-vii333.

Malignant mesothelioma. Rudd R. British Medical Bulletin. 2010. 93: 105-123

Malignant pleural mesothelioma: The standard of care and challenges for future management. van Meerbeeck J, Scherpereel A, Surmont, V, Baas P. 2010. Critical Reviews in Oncology/Hematology. May 11. DOI:10.1016/j.critrevonc.2010.04.004

Mike Snee - Consultant in Oncology
Mr Loic Lang-Lazdunski - Consultant Thoracic Surgeon
Dr J Steele - Consultant in Oncology
Mr D Waller - Consultant Thoracic Surgeon

Dee McLean - McDee Art, Medical Illustration